Vascular aging and hypertension: Implications for the clinical application of central blood pressure

On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG)

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Vascular aging may be responsible for the high residual lifetime risk for hypertension in the middle-aged and elderly individuals. Increased arterial stiffness and wave reflection has been recognized as the dominant hemodynamic manifestations of vascular aging, and both are major determinants of central blood pressure (BP) and independent predictors for incident hypertension. Because central BP is strongly linearly associated with age, it can be regarded as an integrated marker for vascular aging. Central BP can be measured noninvasively using various techniques, including the convenient cuff-based oscillometric central BP monitors. Noninvasive central BP is likely better than the conventional brachial BP in association with target organ damages and long term cardiovascular outcomes. Based on the analysis of the long-term events of derivation and validation cohorts, the central BP threshold of 130/90 mmHg for defining hypertension has been proposed. Recent studies suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional brachial BP strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Vascular aging-related hypertension is expected to become the dominant phenotype in many countries, especially in the Asian regions. Although noninvasive measurement of brachial BP is inaccurate and central BP has been shown to carry superior prognostic value beyond brachial BP, the use of central BP should be justified by studies comparing central blood pressure-guided therapeutic strategies with classic guidelines-guided strategies for preventing cardiovascular events. Future randomized control trials are required to support that the diagnosis and monitoring of vascular aging-related hypertension is best managed with the central BP strategy.

Original languageEnglish
Pages (from-to)209-213
Number of pages5
JournalInternational Journal of Cardiology
Volume230
DOIs
Publication statusPublished - 2017 Mar 1

Fingerprint

Blood Vessels
Blood Pressure
Hypertension
Arm
Blood Pressure Monitors
Vascular Stiffness
Hemodynamics

Keywords

  • Asia
  • Blood pressure
  • Central blood pressure
  • Hypertension
  • Vascular aging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG) (2017). Vascular aging and hypertension: Implications for the clinical application of central blood pressure. International Journal of Cardiology, 230, 209-213. https://doi.org/10.1016/j.ijcard.2016.12.170

Vascular aging and hypertension : Implications for the clinical application of central blood pressure. / On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG).

In: International Journal of Cardiology, Vol. 230, 01.03.2017, p. 209-213.

Research output: Contribution to journalReview article

On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG) 2017, 'Vascular aging and hypertension: Implications for the clinical application of central blood pressure', International Journal of Cardiology, vol. 230, pp. 209-213. https://doi.org/10.1016/j.ijcard.2016.12.170
On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG). Vascular aging and hypertension: Implications for the clinical application of central blood pressure. International Journal of Cardiology. 2017 Mar 1;230:209-213. https://doi.org/10.1016/j.ijcard.2016.12.170
On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG). / Vascular aging and hypertension : Implications for the clinical application of central blood pressure. In: International Journal of Cardiology. 2017 ; Vol. 230. pp. 209-213.
@article{2d16e5653df747afa0ba505a7bedae86,
title = "Vascular aging and hypertension: Implications for the clinical application of central blood pressure",
abstract = "Vascular aging may be responsible for the high residual lifetime risk for hypertension in the middle-aged and elderly individuals. Increased arterial stiffness and wave reflection has been recognized as the dominant hemodynamic manifestations of vascular aging, and both are major determinants of central blood pressure (BP) and independent predictors for incident hypertension. Because central BP is strongly linearly associated with age, it can be regarded as an integrated marker for vascular aging. Central BP can be measured noninvasively using various techniques, including the convenient cuff-based oscillometric central BP monitors. Noninvasive central BP is likely better than the conventional brachial BP in association with target organ damages and long term cardiovascular outcomes. Based on the analysis of the long-term events of derivation and validation cohorts, the central BP threshold of 130/90 mmHg for defining hypertension has been proposed. Recent studies suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional brachial BP strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Vascular aging-related hypertension is expected to become the dominant phenotype in many countries, especially in the Asian regions. Although noninvasive measurement of brachial BP is inaccurate and central BP has been shown to carry superior prognostic value beyond brachial BP, the use of central BP should be justified by studies comparing central blood pressure-guided therapeutic strategies with classic guidelines-guided strategies for preventing cardiovascular events. Future randomized control trials are required to support that the diagnosis and monitoring of vascular aging-related hypertension is best managed with the central BP strategy.",
keywords = "Asia, Blood pressure, Central blood pressure, Hypertension, Vascular aging",
author = "{On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG)} and Cheng, {Hao Min} and Sungha Park and Qifang Huang and Satoshi Hoshide and Wang, {Ji Guang} and Kazuomi Kario and Park, {Chang Gyu} and Chen, {Chen Huan}",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.ijcard.2016.12.170",
language = "English",
volume = "230",
pages = "209--213",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Vascular aging and hypertension

T2 - Implications for the clinical application of central blood pressure

AU - On behalf of the Characteristics On the Management of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG)

AU - Cheng, Hao Min

AU - Park, Sungha

AU - Huang, Qifang

AU - Hoshide, Satoshi

AU - Wang, Ji Guang

AU - Kario, Kazuomi

AU - Park, Chang Gyu

AU - Chen, Chen Huan

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Vascular aging may be responsible for the high residual lifetime risk for hypertension in the middle-aged and elderly individuals. Increased arterial stiffness and wave reflection has been recognized as the dominant hemodynamic manifestations of vascular aging, and both are major determinants of central blood pressure (BP) and independent predictors for incident hypertension. Because central BP is strongly linearly associated with age, it can be regarded as an integrated marker for vascular aging. Central BP can be measured noninvasively using various techniques, including the convenient cuff-based oscillometric central BP monitors. Noninvasive central BP is likely better than the conventional brachial BP in association with target organ damages and long term cardiovascular outcomes. Based on the analysis of the long-term events of derivation and validation cohorts, the central BP threshold of 130/90 mmHg for defining hypertension has been proposed. Recent studies suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional brachial BP strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Vascular aging-related hypertension is expected to become the dominant phenotype in many countries, especially in the Asian regions. Although noninvasive measurement of brachial BP is inaccurate and central BP has been shown to carry superior prognostic value beyond brachial BP, the use of central BP should be justified by studies comparing central blood pressure-guided therapeutic strategies with classic guidelines-guided strategies for preventing cardiovascular events. Future randomized control trials are required to support that the diagnosis and monitoring of vascular aging-related hypertension is best managed with the central BP strategy.

AB - Vascular aging may be responsible for the high residual lifetime risk for hypertension in the middle-aged and elderly individuals. Increased arterial stiffness and wave reflection has been recognized as the dominant hemodynamic manifestations of vascular aging, and both are major determinants of central blood pressure (BP) and independent predictors for incident hypertension. Because central BP is strongly linearly associated with age, it can be regarded as an integrated marker for vascular aging. Central BP can be measured noninvasively using various techniques, including the convenient cuff-based oscillometric central BP monitors. Noninvasive central BP is likely better than the conventional brachial BP in association with target organ damages and long term cardiovascular outcomes. Based on the analysis of the long-term events of derivation and validation cohorts, the central BP threshold of 130/90 mmHg for defining hypertension has been proposed. Recent studies suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional brachial BP strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Vascular aging-related hypertension is expected to become the dominant phenotype in many countries, especially in the Asian regions. Although noninvasive measurement of brachial BP is inaccurate and central BP has been shown to carry superior prognostic value beyond brachial BP, the use of central BP should be justified by studies comparing central blood pressure-guided therapeutic strategies with classic guidelines-guided strategies for preventing cardiovascular events. Future randomized control trials are required to support that the diagnosis and monitoring of vascular aging-related hypertension is best managed with the central BP strategy.

KW - Asia

KW - Blood pressure

KW - Central blood pressure

KW - Hypertension

KW - Vascular aging

UR - http://www.scopus.com/inward/record.url?scp=85009376411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009376411&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.12.170

DO - 10.1016/j.ijcard.2016.12.170

M3 - Review article

C2 - 28043670

AN - SCOPUS:85009376411

VL - 230

SP - 209

EP - 213

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -